drugset / Trial / NCT00310596
Cardiovascular Safety Study of Magnevist® Injection at Two Dose Levels and Two Injection Rates in Normal Subjects
RandomizedCrossoverTriple-blindDiagnostic
Summary
The purpose of this study is to determine what effect Magnevist (gadopentetate dimeglumine) injection has on the way the heart conducts the electrical impulses that allow it to beat effectively. The study will compare Magnevist injection's effect to that of placebo (a saline injection).
Timeline
- Start
- 2004-01
- Primary completion
- —
- Completion
- 2004-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Gadopentetate dimeglumine | Diagnostic / imaging agent | 0.1 mmol | — |
| Subject | Gadopentetate dimeglumine | Diagnostic / imaging agent | 0.3 mmol | — |
| Comparator | Moxifloxacin | Small molecule | 400 mg | — |
Indications
No indication recorded.